CSNK1E - Casein Kinase 1 Epsilon

CSNK1E - Casein Kinase 1 Epsilon

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CSNK1E - Casein Kinase 1 Epsilon</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CSNK1E</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Casein Kinase 1 Epsilon</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q21.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[1454](https://www.ncbi.nlm.nih.gov/gene/1454)</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>[604066](https://www.omim.org/entry/604066)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000101391</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P49674](https://www.uniprot.org/uniprot/P49674)</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[PER1](/genes/per1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[PER2](/genes/per2)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[CRY1](/genes/cry1)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[CLOCK](/genes/clock)</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">[BMAL1](/genes/arntl)</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">[TAU](/genes/mapt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[SNCA](/genes/snca)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[LRRK2](/genes/lr

...

CSNK1E - Casein Kinase 1 Epsilon

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CSNK1E - Casein Kinase 1 Epsilon</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CSNK1E</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Casein Kinase 1 Epsilon</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q21.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[1454](https://www.ncbi.nlm.nih.gov/gene/1454)</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>[604066](https://www.omim.org/entry/604066)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000101391</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P49674](https://www.uniprot.org/uniprot/P49674)</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[PER1](/genes/per1)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[PER2](/genes/per2)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[CRY1](/genes/cry1)</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">[CLOCK](/genes/clock)</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">[BMAL1](/genes/arntl)</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">[TAU](/genes/mapt)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[SNCA](/genes/snca)</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">[LRRK2](/genes/lrrk2)</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>

Introduction

Csnk1E Casein Kinase 1 Epsilon is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

[@tau2004]

Overview

This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to [Alzheimer's disease](/diseases/alzheimers-disease), Parkinson's disease, and related conditions.

se), [Parkinson's Disease](/diseases/parkinsons-disease) |

Function

CSNK1E encodes casein kinase 1 epsilon (CK1ε), a serine/threonine protein kinase that plays essential roles in circadian rhythm regulation, [Wnt signaling](/mechanisms/wnt-signaling), [DNA repair](/mechanisms/dna-repair-neurodegeneration)), and various neuronal signaling pathways. CK1ε is a member of the casein kinase 1 family, which includes seven isoforms (CK1α, CK1β, CK1γ1-3, CK1δ, CK1ε) with distinct subcellular localizations and functions.

Enzyme Structure and Activity

CK1ε is a 409-amino acid protein kinase with the following features:

• Kinase domain (1-300 aa): Catalytic domain with ATP binding site
• C-terminal tail (300-409 aa): Regulatory domain with autophosphorylation sites
• Nuclear localization signals: Directs nuclear import
• Dimerization domain: Enables dimer formation

Catalytic Properties

CK1ε phosphorylates substrates with the consensus sequence:
Ser/Thr - X - X - Ser/Thr (where X is any amino acid)

Key substrate characteristics:

• Pre-phosphorylated serine/threonine enhances activity
• Multiple phosphorylation sites create "phosphorylation clusters"
• Substrate specificity determined by surrounding sequence

Biological Functions

Circadian Rhythm Regulation

CK1ε is a core component of the [circadian clock](/mechanisms/circadian-rhythm), phosphorylating:

PER Protein Phosphorylation

PER1/PER2/PER3 phosphorylation: CK1ε phosphorylates PERIOD proteins

Temporal degradation: Phosphorylation targets PER for ubiquitinylation

CRY stabilization: CK1ε also affects cryptochrome stability

Transcriptional feedback: Controls negative feedback loop timing

Clock Mechanism

The circadian clock consists of transcription-translation feedback loops:

• BMAL1/CLOCK: Activator complex driving transcription
• PER/CRY: Repressor complex inhibiting their own expression
• CK1ε/CK1δ: Rate-limiting kinases controlling PER stability
• Casein kinase 1: Sets the period length of the rhythm

Mutations in CSNK1E alter circadian period length [1](https://pubmed.ncbi.nlm.nih.gov/11441146/).

Wnt Signaling

CK1ε modulates the [Wnt/β-catenin pathway](/mechanisms/wnt-signaling):

• Dishevelled phosphorylation: Activates Dvl, upstream Wnt signaling
• β-catenin degradation: Modifies destruction complex activity
• Planar cell polarity: Regulates PCP pathway signaling
• Neuronal development: Controls axon guidance and dendrite morphogenesis

DNA Repair

CK1ε participates in [DNA damage response](/mechanisms/dna-damage-response):

• p53 phosphorylation: Activates tumor suppressor
• MDC1 phosphorylation: Facilitates DNA damage response
• Chk1 modulation: Affects cell cycle checkpoints
• Telomere maintenance: Regulates telomere length and function

Neuronal Signaling

CK1ε regulates numerous neuronal processes:

• Synaptic plasticity: Modulates AMPA receptor trafficking
• Dopaminergic signaling: Affects dopamine transporter function
• [NMDA receptor](/entities/nmda-receptor) regulation: Controls receptor localization
• Axonal transport: Phosphorylates transport regulatory proteins

Disease Associations

Circadian Rhythm Disorders

CK1ε mutations cause familial advanced sleep phase syndrome (FASPS):

• Advanced sleep phase: Early bedtime and wake time
• Short circadian period: ~22 hours instead of 24 hours
• T47N mutation: Reduced PER2 phosphorylation, advanced phase
• Delayed variant: Some mutations cause delayed sleep

Neurodegenerative Diseases

CK1ε dysregulation contributes to several neurodegenerative conditions:

Alzheimer's Disease

• [Tau](/proteins/tau) hyperphosphorylation: CK1ε phosphorylates tau at multiple sites
• Amyloid processing: Affects [APP](/entities/app-protein) cleavage and [Aβ](/proteins/amyloid-beta) production
• Circadian disruption: Contributes to sleep-wake cycle abnormalities
• Neuronal loss: Contributes to progressive neurodegeneration

Parkinson's Disease

• [α-Synuclein](/proteins/alpha-synuclein) phosphorylation: CK1ε phosphorylates α-syn at S129
• Dopaminergic dysfunction: Alters dopamine signaling
• Circadian abnormalities: PD patients show disrupted rhythms
• [LRRK2](/entities/lrrk2) interaction: May modulate LRRK2 function

Migraine

• Periodic limb movements: CK1ε variants associated with restless legs
• Pain signaling: Modulates trigeminal pain pathways
• Cortical spreading depression: Involved in migraine aura

Neurodegeneration Mechanisms

Tau Pathology

CK1ε is a major tau kinase:

• Multiple phosphorylation sites: S262, S356, T181, T231, S396
• Hyperphosphorylation: Contributes to neurofibrillary tangles
• Microtubule dissociation: Phosphorylated tau loses binding ability
• Aggregation propensity: Phosphorylation promotes fibril formation

Protein Aggregation

CK1ε affects aggregation pathways:

• α-Synuclein phosphorylation: S129 phosphorylation in Lewy bodies
• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: Modulates TDP-43 aggregation
• [Autophagy](/entities/autophagy) regulation: Phosphorylates autophagy proteins

Circadian Disruption

Altered circadian function contributes to neurodegeneration:

• Sleep-wake abnormalities: Common in AD and PD
• Metabolic dysregulation: Altered cellular metabolism
• Oxidative stress: Circadian-regulated antioxidant pathways
• Inflammation: Circadian control of immune function

Therapeutic Implications

CK1ε Inhibitors

Several CK1ε inhibitors are in development:

• PF-670462: Brain-penetrant CK1δ/ε inhibitor
• PF-4800567: CK1ε-selective inhibitor
• IC261: CK1δ/ε inhibitor
• D4476: CK1 family inhibitor

Potential applications:

• Tauopathies: Reduce tau phosphorylation
• Circadian disorders: Reset circadian phase
• Neuroprotection: Enhance neuronal survival

Drug Development Strategies

• [Blood-brain barrier](/entities/blood-brain-barrier) penetration: Critical for CNS therapies
• Isoform selectivity: Target CK1ε over CK1δ
• Timing optimization: Circadian-appropriate dosing

Interacting Proteins

Research Models

Animal Models

• CSNK1E knockout mice: Viable with subtle circadian defects
• Transgenic models: Overexpression of mutant forms
• Knock-in models: Human FASPS mutations

Cell Culture

• Primary [neurons](/entities/neurons): Study neuronal CK1ε function
• Circadian cell lines: PER2-luc reporter cells
• Patient-derived cells: iPSC modeling

Summary

CSNK1E encodes casein kinase 1 epsilon, a serine/threonine kinase critical for circadian rhythm regulation, Wnt signaling, and neuronal function. CK1ε phosphorylates core clock proteins (PER, CRY), tau, and α-synuclein, linking circadian dysfunction to neurodegenerative pathologies. Mutations cause circadian rhythm disorders, while dysregulation contributes to Alzheimer's disease, Parkinson's disease, and migraine. CK1ε inhibitors represent potential therapeutic agents for tauopathies and circadian disorders.

Background

The study of Csnk1E Casein Kinase 1 Epsilon has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• [Circadian Rhythm](/mechanisms/circadian-rhythm-neurodegeneration)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Wnt Signaling](/mechanisms/wnt-signaling)
• Protein Kinases

References

[Unknown, CK1ε and circadian period (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11441146/)

[Unknown, CK1ε in tau phosphorylation (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/14749355/)

[Unknown, Casein kinases in neurodegeneration (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25823552/)

[Unknown, Circadian disruption in AD (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31026987/)

[Unknown, CK1ε inhibitors for tauopathies (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32084325/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CSNK1E - Casein Kinase 1 Epsilon discovered through SciDEX knowledge graph analysis: